Forte Biosciences, Inc. Announces Second Quarter 2020 Results and Provides General Business Update
TORRANCE, Calif.--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the…
